Apogee Therapeutics
Stock Forecast, Prediction & Price Target
Apogee Therapeutics Financial Estimates
Apogee Therapeutics Revenue Estimates
Apogee Therapeutics EBITDA Estimates
Apogee Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 | |
Revenue
% change YoY
| $0 N/A | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
Net Income
% change YoY
| $-39.78M N/A | $-83.98M -111.09% | Avg: $-200.57M Low: $-279.11M High: $-120.56M avg. -138.82% | Avg: $-282.84M Low: $-349.01M High: $-142.34M avg. -41.01% | Avg: $-254.46M Low: $-254.46M High: $-254.46M avg. 10.03% | Avg: $-307.14M Low: $-307.14M High: $-307.14M avg. -20.70% | |
EBITDA
% change YoY
| $-30.72M N/A | $-83.98M -173.32% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$0.79 N/A | -$0 99.56% | Avg: -$3.24 Low: -$5.51 High: -$2.38 avg. -95194.11% | Avg: -$4.05 Low: -$6.89 High: -$2.81 avg. -24.99% | Avg: -$5.02 Low: -$5.02 High: -$5.02 avg. -24.03% | Avg: -$6.06 Low: -$6.06 High: -$6.06 avg. -20.70% | |
Operating Expenses
% change YoY
| $30.72M N/A | $93.00M 202.67% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
FAQ
What is Apogee Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -47.62% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -279.11M, average is -200.57M and high is -120.56M.
What is Apogee Therapeutics stock revenue growth forecast?
We have gathered data from 5 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Apogee Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -23815.96% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$5.51, average is -$3.24 and high is $-2.38.
What is the best performing analyst?
In the last twelve months analysts have been covering Apogee Therapeutics stock. The most successful analyst is Alex Thompson.